Clinical Trial Update: CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial evaluating CB-103 in combination with either lenvatinib or abemaciclib for Adenoid Cystic Carcinoma, including metastatic or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma

Drugs mentioned

• CB-103
• LENVIMA (lenvatinib)
• VERZENIO (ABEMACICLIB)

Snippet

Sponsor: Glenn J. Hanna | Conditions: Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma | Phase 1, Phase 2 | Status: RECRUITING